Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Published:2017-04 Issue: Volume:52 Page:214-227
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Chiotis Konstantinos,Saint-Aubert Laure,Boccardi Marina,Gietl Anton,Picco Agnese,Varrone Andrea,Garibotto Valentina^ORCID,Herholz Karl,Nobili Flavio,Nordberg Agneta,Frisoni Giovanni B.,Winblad Bengt,Jack Clifford R

Funder

Swiss National Science Foundation

Alzheimer Forum Switzerland

Association pour la Recherche sur Alzheimer

Piramal

Eli Lilly and Company

General Electric

Guerbet

TEVA Pharma

Academie Suisse de Sciences Médicales

Vifor Pharma Switzerland

Novartis

Siemens

IXICO

Swedish Research Council

Swedish Brain Power

Swedish Foundation for Strategic Research (SSF)

Wenner-Gren Foundation

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference130 articles.

1. The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients,1995

2. Amyloid-PET as a diagnostic marker in daily practice,1995

3. Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B;Adamczuk;Eur. J. Nucl. Med. Mol. Imaging,2016

4. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease;Agdeppa;J. Neurosci.,2001

5. Frequent amyloid deposition without significant cognitive impairment among the elderly;Aizenstein;Arch. Neurol.,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study;Molecular Psychiatry;2024-08-23

2. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET;PLOS ONE;2024-05-20

3. PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2024-03-04

4. Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-15

5. How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment;Alzheimer's Research & Therapy;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3